sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the

0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83

same period previous year is decrease of Baht 30.90 million or 66.04% due to the company recognized the share of loss from investment in an associated company in the amount of Baht 33.08 million. The

(Million Baht: MB) (MB) % (MB) % Revenue from Sales and Service 2,179.9 1,137.4 1,745.2 1,042.5 91.7 434.7 24.9 Cost of Sales and Service 1,820.0 909.4 1,516.0 910.6 100.1 304.0 20.1 Selling and distribution

selling and administrative expenses 114,629 96,763 17,866 18.5 113,022 94,348 18,674 19.8 Selling and distribution expenses 27,060 25,061 1,999 8.0 24,468 22,708 1,760 7.8 Administrative expenses 44,206

engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis services

attributable to owner of the parent 150.57 267.77 (117.20) (43.77%) 465.05 609.48 (144.42) (23.70%) Earnings per share (EPS) 0.09 0.16 (0.07) (43.77%) 0.28 0.37 (0.09) (23.70%) Raw water costs 52% Tap water

December 2019 for an additional 0.04 baht per share, which was the dividend from the profit exempted from corporate income tax, amounting to 12,000,013.60 baht. The Company will identify rightful

clarifies the performance as follows: During the first quarter of 2020, the Company had the total revenue and share of profit and net profit of THB 1,277.8 mm and THB 99.3 mm, respectively. If excluding FX

302.67 (61.26) (16.83%) Earnings per share (EPS) 0.22 0.18 (0.04) (16.83%) Note: 1) Revenue and Cost that were recognized when there is construction under concession agreements for tap water according to